Literature DB >> 690027

Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients.

J P Fillastre, A Leroy, M Godin, G Oksenhendler, G Humbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 690027     DOI： 10.1093/jac/4.suppl_b.79

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.

Authors:  S Srinivasan; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

2.  Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.

Authors:  M Ohkawa; M Orito; T Sugata; M Shimamura; M Sawaki; E Nakashita; K Kuroda; K Sasahara
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

3.  Cefoxitin: intravenous pharmacokinetics and intramuscular bioavailability in kwashiorkor.

Authors:  N Buchanan; Y Mithal; M Witcomb
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

4.  Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.

Authors:  M Ohkawa; S Hirano; S Tokunaga; I Motoi; R Shoda; A Ikeda; T Sugata; M Sawaki; M Shimamura; A Okasho; K Kuroda
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 5.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

6.  Cefoxitin disposition during peritoneal dialysis.

Authors:  W L Greaves; J H Kreeft; R I Ogilvie; G K Richards
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

7.  Elimination kinetics of ceftizoxime in humans with and without renal insufficiency.

Authors:  M Ohkawa; A Okasho; T Sugata; K Kuroda
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

Review 8.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

9.  Interference of cefoxitin in the creatinine estimation and its clinical relevance.

Authors:  S R Durham; A H Bignell; R Wise
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.